ALGS

MKT CAP:$33M

Aligos Therapeutics Inc

Market Cap

$33M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$4.91-$4.22 (-46.22%)

Jun 5, 2026

52W High $13.2952W Low $4.91

Company Details

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agoni...

CEO

—

IPO Date

Oct 16, 2020

Website

www.aligos.com

Key Metrics TTM

Revenue

$5M

+43.9% YoY

Net Income

-$90M

EPS (Diluted)

Free Cash Flow

-$85M

Revenue / Share

$0.45

Gross Margin

89.0%

Operating Margin

-2033.4%

Net Margin

-1919.7%

FCF Margin

-1810.5%

P/S

7.0x

P/E

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

May 7, 2026

$3M+810.0%

FY 2025

Mar 5, 2026

$2M-44.6%

Q4 2025

Mar 5, 2026

$169.0K-73.1%

Q3 2025

Nov 6, 2025

$741.0K-41.6%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee